Analisis Keuangan Saham FGEN - FibroGen, Inc. (BMV) Stock

Gambaran Umum

FibroGen, Inc. is a biopharmaceutical company based in the United States, specifically headquartered in San Francisco, California. Established in 1993, the company predominantly operates within the biotechnology industry, focusing on the discovery, development, and commercialization of novel therapeutics. FibroGen is particularly recognized for its pioneering research in the field of hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, which form the basis of therapies aimed at treating anemia, fibrotic disease, and cancer. A key project includes Roxadustat, an oral medication designed to treat anemia associated with chronic kidney disease, reflecting the company's strategic focus on addressing severe unmet medical needs. FibroGen’s ongoing projects and innovations continue to reinforce its reputation in medical research, underpinned by collaborations with global pharmaceutical leaders to enhance drug development and accessibility.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk FibroGen, Inc. per 2025 Jun 30 adalah 7.35 MM.
Nilai operating income untuk FibroGen, Inc. per 2025 Jun 30 adalah -61.83 MM.
Nilai net income untuk FibroGen, Inc. per 2025 Jun 30 adalah -2.07 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	7.35	-61.83	-2.07
2025-03-31	7.00	-96.57	-10.01
2024-12-31	29.62	-130.96	-47.58
2024-09-30	-1.11	-213.55	-121.79
2024-06-30	-7.31	-266.20	-168.32
2024-03-31	36.01	-307.84	-240.46
2023-12-31	46.80	-334.75	-284.23
2023-09-30	154.98	-281.17	-294.18
2023-06-30	130.58	-323.95	-322.21
2023-03-31	116.07	-314.12	-307.15
2022-12-31	140.73	-301.02	-293.65
2022-09-30	122.91	-370.11	-361.56
2022-06-30	263.15	-225.48	-220.11
2022-03-31	257.71	-281.10	-281.47
2021-12-31	235.31	-348.53	-290.02
2021-09-30	283.76	-211.29	-214.58
2021-06-30	171.82	-229.93	-231.37
2021-03-31	190.35	-181.23	-182.70
2020-12-31	176.32	-191.88	-189.29
2020-09-30	119.29	-234.32	-228.78
2020-06-30
2020-03-31

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	-0.48
2024-09-30	-1.22	-1.22
2024-06-30	-1.70	-1.70
2024-03-31	-2.44	-2.44
2023-12-31	-2.92
2023-09-30	-3.06	-3.06
2023-06-30	-3.39	-3.39
2023-03-31	-3.27	-3.27
2022-12-31	-3.14
2022-09-30	-3.88	-3.88
2022-06-30	-2.37	-2.37
2022-03-31	-3.04	-3.04
2021-12-31	-3.14
2021-09-30	-2.33	-2.33
2021-06-30	-2.53	-2.53
2021-03-31	-2.01	-2.01
2020-12-31	-2.11
2020-09-30	-2.57	-2.57
2020-06-30	-3.54	-3.54
2020-03-31	-1.26	-1.26

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk FibroGen, Inc. per 2025 Jun 30 adalah -23.44 MM.
Nilai cash from investing activities untuk FibroGen, Inc. per 2025 Jun 30 adalah 2.45 MM.
Nilai kas dari aktivitas pendanaan untuk FibroGen, Inc. per 2025 Jun 30 adalah -0.22 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	-23.44	2.45	-0.22
2025-03-31	-75.99	74.70	-0.18
2024-12-31	-138.00	125.99	-0.26
2024-09-30	-125.85	134.51	-0.51
2024-06-30	-202.02	187.97	-0.40
2024-03-31	-272.72	101.45	91.10
2023-12-31	-315.02	153.66	122.75
2023-09-30	-349.21	144.51	171.67
2023-06-30	-316.56	135.07	170.60
2023-03-31	-239.05	166.66	81.15
2022-12-31	-145.93	89.12	46.78
2022-09-30	-148.38	37.46	-1.93
2022-06-30	-52.24	-129.48	-1.67
2022-03-31	-45.72	-204.32	-1.38
2021-12-31	-82.23	-426.97	-0.56
2021-09-30	-34.50	-232.64	5.13
2021-06-30	-80.10	-11.63	10.19
2021-03-31	96.10	199.76	12.45
2020-12-31	81.60	452.49	13.34
2020-09-30	43.78	283.69	7.40
2020-06-30
2020-03-31

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Efektivitas Manajemen

roe untuk FibroGen, Inc. pada 2025 Jun 30 adalah 0.00.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30		0.00
2025-03-31		0.00
2024-12-31		0.00
2024-09-30		0.00
2024-06-30		0.00
2024-03-31		0.00
2023-12-31		0.00
2023-09-30		0.00
2023-06-30		0.00
2023-03-31		0.00
2022-12-31		0.00
2022-09-30		0.00
2022-06-30		0.00
2022-03-31		0.00
2021-12-31		0.00
2021-09-30		0.00
2021-06-30		0.00
2021-03-31		0.00
2020-12-31	-0.22	-0.35	-0.38	1.10	0.16
2020-09-30	-0.26	-0.37	-0.43	0.63	0.08
2020-06-30	-0.34	-0.48	-0.65	0.74	0.04
2020-03-31	-0.14	-0.22	-0.20	0.07	-0.30

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31	-0.48	-1.07	-1.09
2020-09-30	-1.00	-1.92	-1.96
2020-06-30	-1.11	-2.87	-2.95
2020-03-31	0.16	-0.43	-0.47

DE:1FG0
GB:0IL8
US:FGEN	US$ 12.10